|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Siegel R, Ward E, Hao Y, Xu J and
Thun MJ: Cancer statistics, 2009. CA Cancer J Clin. 59:225–249.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dunne EF and Park IU: HPV and
HPV-associated diseases. Infect Dis Clin North Am. 27:765–778.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
EsquelaKerscher A and Slack FJ:
Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer.
6:259–269. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin PY, Yu SL and Yang PC: MicroRNA in
lung cancer. Br J Cancer. 103:1144–1148. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amer M, Elhefnawi M, ElAhwany E, Awad AF,
Gawad NA, Zada S and Tawab FM: Hsa-miR-195 targets PCMT1 in
hepatocellular carcinoma that increases tumor life span. Tumour
Biol. 35:11301–11309. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Y, Li M, Chang S, Wang L, Song T, Gao
L, Hu L, Li Z, Liu L, Yao J and Huang C: MicroRNA-195 acts as a
tumor suppressor by directly targeting Wnt3a in HepG2
hepatocellular carcinoma cells. Mol Med Rep. 10:2643–2648.
2014.PubMed/NCBI
|
|
9
|
Yongchun Z, Linwei T, Xicai W, Lianhua Y,
Guangqiang Z, Ming Y, Guanjian L, Yujie L and Yunchao H:
MicroRNA-195 inhibits non-small cell lung cancer cell
proliferation, migration and invasion by targeting MYB. Cancer
Lett. 347:65–74. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang QQ, Xu H, Huang MB, Ma LM, Huang QJ,
Yao Q, Zhou H and Qu LH: MicroRNA-195 plays a tumor-suppressor role
in human glioblastoma cells by targeting signaling pathways
involved in cellular proliferation and invasion. Neuro Oncol.
14:278–287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo Q, Wei C, Li X, Li J, Chen L, Huang Y,
Song H, Li D and Fang L: MicroRNA-195-5p is a potential diagnostic
and therapeutic target for breast cancer. Oncol Rep. 31:1096–1102.
2014.PubMed/NCBI
|
|
12
|
Liu L, Chen L, Xu Y, Li R and Du X:
MicroRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xiong Y, Menninger J, Beach D and Ward DC:
Molecular cloning and chromosomal mapping of CCND genes encoding
human D-type cyclins. Genomics. 13:575–584. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen Y, Xu H, Liu J, Zhang C, Leutz A and
Mo X: The c-Myb functions as a downstream target of PDGF-mediated
survival signal in vascular smooth muscle cells. Biochem Biophys
Res Commun. 360:433–436. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Nigg EA: Cyclin-dependent protein kinases:
Key regulators of the eukaryotic cell cycle. Bioessays. 17:471–480.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Meyerson M and Harlow E: Identification of
G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell
Biol. 14:2077–2086. 1994.PubMed/NCBI
|
|
17
|
Ortega S, Malumbres M and Barbacid M:
Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim
Biophys Acta. 1602:73–87. 2002.PubMed/NCBI
|
|
18
|
Sato T, Yamamoto T and Sehara-Fujisawa A:
MiR-195/497 induce postnatal quiescence of skeletal muscle stem
cells. Nat Commun. 5:45972014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roussel M, Saule S, Lagrou C, Rommens C,
Beug H, Graf T and Stehelin D: Three new types of viral oncogene of
cellular origin specific for haematopoietic cell transformation.
Nature. 281:452–455. 1979. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ramsay RG and Gonda TJ: MYB function in
normal and cancer cells. Nat Rev Cancer. 8:523–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
